Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DM32IV4)

Drug Name
RG7593 Drug Info
Indication
Disease Entry ICD 11 Status REF
Haematological malignancy 2B33.Y Discontinued in Phase 2 [1]
Cross-matching ID
TTD Drug ID
DM32IV4

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
B-cell receptor CD22 (CD22) TTM6QSK CD22_HUMAN Modulator [2]

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Haematological malignancy
ICD Disease Classification 2B33.Y
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
B-cell receptor CD22 (CD22) DTT CD22 1.89E-11 -0.21 -0.58
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027651)
2 Clinical pipeline report, company report or official report of Roche.